NCT06860594 2026-03-18Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaNational Cancer Institute (NCI)Phase 1 Recruiting30 enrolled
NCT05765812 2026-02-27A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaDebiopharm International SAPhase 1/2 Recruiting116 enrolled
NCT02586857 2026-01-12A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)Acerta Pharma BVPhase 1/2 Active not recruiting24 enrolled 10 charts
NCT07285044 2025-12-22The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasMayo ClinicPhase 2 Recruiting27 enrolled